Phoenix Holdings Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

Phoenix Holdings Ltd.

  • $6.66 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$159.56 - $209.29 $206,789 - $271,239
-1,296 Closed
0 $0
Q3 2021

Oct 27, 2021
BUY
$169.75 - $207.73 $219,996 - $269,218
1,296 New
1,296 $229,000
Q2 2021

Aug 10, 2021
SELL
$128.63 - $176.89 $191,658 - $263,566
-1,490 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$126.83 - $175.69 $188,976 - $261,778
1,490 New
1,490 $201,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email